A review of factors influencing the implantation of euploid blastocysts after in vitro fertilization

Noninvasive preimplantation genetic testing for aneuploidy in spent culture medium as a substitute for trophectoderm biopsy

Day 2 embryo transfer (ET) and day 3 ET afford similar reproductive outcomes in the poor responder

Reflections on preimplantation genetic testing for aneuploidy and mosaicism: how did we get here, and what does it mean clinically?

Clinical outcomes for various causes of infertility with natural-cycle in vitro fertilization combined with in vitro maturation of immature oocytes

Impact of the presence of one or more multinucleated blastomeres on the developmental potential of the embryo to the blastocyst stage

Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting

Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve

Response: how PGS/PGT-a laboratories succeeded in losing all credibility.

Frozen embryo transfer: evidence-based markers for successful endometrial preparation

Endometrial thickness: How thin is too thin?

Should patients be screened for chronic endometritis before assisted reproductive technology?

Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial

Ten-year experience with preimplantation genetic diagnosis (PGD) at the New York University School of Medicine Fertility Center

Substandard application of preimplantation genetic screening may interfere with its clinical success

Recurrent IVF failure: other factors